Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.
Press releases published on October 27, 2025
Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism with DCAF16 E3 ligase published in Nature Communications
The publication reports the highly selective, DCAF16 E3 enabled degradation of BRD9 in vivo using Amphista’s proprietary, next generation Targeted Glue™ medicinal chemistry technology Amphista’s scientists prospectively and rationally designed therapeutic …
Red Cat Successfully Completes Flight Testing of Palantir’s VNav Software on Black Widow™ Drone
SAN JUAN, Puerto Rico, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat'' or the "Company"), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today announced the …
RAGNAROK 3 (Chinese Title: 仙境传说3) Received an ISBN Code by Chinese Government
Seoul, South Korea, Oct. 27, 2025 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced that RAGNAROK 3 (Chinese Title: 仙境传说3), an MMORPG Mobile and PC game, …
Award-Winning Platform DataGlobal Hub Celebrates Global Impact of its Community, Announces Strategic Partnership with Strategemist
PHOENIX, Oct. 27, 2025 (GLOBE NEWSWIRE) -- DataGlobal Hub, the award-winning technology consortium recognized as the "Technology News Platform of the Year" at the CorporateLiveWire Innovation …
Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis
In a Phase II trial, LEVI-04 demonstrated a significant, dose-dependent reduction in bone marrow lesions (BML) compared with placebo in patients with osteoarthritis (OA) A significant correlation between improvements in OA symptoms and positive effects on …
BIO-key International and IT2Trust Partner to Strengthen IAM and Biometric Security Across the Nordic Region of Denmark, Sweden, Norway and Finland
COPENHAGEN, Denmark and HOLMDEL, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovator in biometric authentication and Identity and Access Management (IAM) solutions, today announced a new partnership with …
DeLeion Capital Trust Service Platform Leads the Next Wave of Digital Asset Management — BTC Rally, Fuels Global Investment Momentum
Kansas City, Kansas, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Deleion Capital highlights the opportunity as there is a globe surge in the digital assets as the BTC is gaining momentum. The global cryptocurrency market is witnessing renewed momentum as Bitcoin …
Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference
VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at the AACR-NCI-EORTC International Conference on …
Humanoid Global Welcomes Saman Farid to its Investment Advisory Board
Vancouver, BC, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering …
DeLeion Capital Announces Launch of Regulated Cryptocurrency Custody Plans, Marking a New Era of Secure and Intelligent Digital Asset Management
Los Angeles, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- DeLeion Capital today announced the launch of its regulated cryptocurrency custody and digital asset management platform, establishing a new benchmark for security, compliance, and stability in the global …
Citryll Presents Positive Data from Phase I Study of CIT-013 in Rheumatoid Arthritis at ACR Convergence 2025
CITRYLL PRESENTS POSITIVE DATA FROM PHASE I STUDY OF CIT-013 IN RHEUMATOID ARTHRITIS AT ACR CONVERGENCE 2025 Phase I trial data in rheumatoid arthritis patients demonstrates favorable safety, encouraging clinical activity, and robust biomarker responses …
World's First Multi-Omics LLM, Promising to Decode the Language of Human Biology Showcasing in Global Health Exhibition, Riyadh
DUBAI, United Arab Emirates, Oct. 27, 2025 (GLOBE NEWSWIRE) -- For the first time, the human body’s most complex data—the intricate conversations between our genes, proteins, and metabolites—can be understood not as isolated signals, but as a coherent …
Bodor Laser Honored at Red Dot Award: Design Concept 2025 Ceremony
SINGAPORE, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Bodor Laser, a global leader in laser cutting and welding solutions, received high recognition at the Red Dot Award: Design Concept 2025 ceremony in Singapore. Three flagship products—the next-generation …
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced that it has entered into a securities purchase agreement with institutional investors to purchase 4,285,715 American …